The diagnostic criteria for MS reflect a growing understanding of the condition and the application of new advancements in medical technology to help improve diagnostic accuracy and reliability.

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by Roche, the test is ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...

Presentation raises questions about EBV timing. Dalia Rotstein, MD, of the University of Toronto, discussed the findings and their implications in an oral presentation at the Amer ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

No single test can confirm multiple sclerosis (MS) or discount it. Instead, doctors test for MS by ruling out other possible diagnoses and then looking for signs of MS-related damage. MS is an ...

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...

Multiple sclerosis MS book and prescription and pen. A blood test might predict relapses in MS Neurofilament light chain levels spike in MS patients’ blood before a relapse However, the prediction ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...